首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1741556

全球低剂量肠外药物市场按配方、剂型、包装类型、适应症、最终用户和地区划分

Global Small Volume Parenteral Market, By Form, By Dose Type, By Packaging Type, By Indication Type, By End User, By Geography

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 172 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球低容量肠外药物市场规模估计为 2,075.7 亿美元，预计到 2032 年将达到 3,443.7 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 7.5%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	2075.7亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	7.50%	2032年价值预测	3443.7亿美元

低容量肠外给药市场包括以小剂量（通常少于 100 毫升）给药的肠外给药药物和製剂。低容量肠外给药广泛应用于糖尿病、癌症、感染疾病、郁血性心臟衰竭疾病的治疗。药物可以透过静脉注射、肌肉、皮下和皮内给药等途径直接进入血液。由于全球慢性和急性疾病的流行，低容量肠外给药市场正在稳步增长。此外，老年人口的成长（他们容易出现多种健康问题）推动了对易于小剂量给药的药物的需求。然而，对肠外给药药物生产的严格规定和与市场发展相关的高成本可能会在一定程度上阻碍市场扩张。

市场动态：

全球低剂量肠外药物市场主要受糖尿病、心血管疾病、癌症和呼吸系统疾病等慢性病盛行率上升的推动。根据世界卫生组织 (WHO) 估计，到 2020 年，慢性病将占全球死亡人数的 70% 以上。此外，老年人口不断增长，容易出现多种健康问题，这也推动了对低剂量肠外药物的需求，以治疗复杂的病症。此外，精准剂量、药物即时输送和绕过胃肠道吸收等优势正在推动低剂量肠外药物的应用。然而，肠外药物开发的高成本和注射药物生产的严格法律规范继续限制市场成长。同时，新型药物输送系统的进步有望为相关人员创造有利可图的机会。

本研究的主要特点

本报告对全球低容量肠外药物市场进行了详细分析，并以 2024 年为基准年，展示了预测期 2025-2032 的市场规模和年复合成长率(CAGR)。
它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
全球小容量肠外药物市场的主要企业已根据公司亮点、产品系列、关键亮点、财务业绩和策略等参数进行了分析。
本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
全球低剂量肠外药物市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员将透过用于分析全球小容量肠外药物市场的各种策略矩阵来做出决策。

Fresenius Kabi AG
- 公司简介
- 产品/服务组合
- 财务表现
- 最新动态/更新
Strategic Overview
Baxter
Sichuan Kelun
BML Parenteral Drugs
ICU Medical, Inc.
Pfizer Inc.
Becton Dickinson and Company
B. Braun Melsungen AG
WuXi AppTec
Akums Drugs &Pharmaceuticals Ltd.
Orion Corporation
Rusoma Laboratories Private Limited
Higgs Healthcare
Syntegon Technology GmbH

第 11 章参考文献与调查方法

参考
调查方法

简介目录

Product Code: CMI6522

Global Small Volume Parenteral Market is estimated to be valued at USD 207.57 Bn in 2025 and is expected to reach USD 344.37 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.5% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 207.57 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.50%	2032 Value Projection:	USD 344.37 Bn

The small volume parenteral market consists of parenteral drugs and formulations administered in small volumes usually less than 100 milliliter. Small volume parenteral find widespread application in treating conditions such as diabetes, cancer, infections, and congestive heart failures. They aid in delivering medications directly into the bloodstream through routes such as intravenous, intramuscular, subcutaneous, and intradermal delivery. The small volume parenteral formulations market has been witnessing steady growth driven by the growing prevalence of chronic and acute diseases worldwide. Moreover, the rising geriatric population prone to multiple health conditions has boosted the demand for easily administrable drugs in mini doses. However, stringent regulations for manufacturing parenteral drugs and high costs that are associated with drug development may impede the market expansion to some extent.

Market Dynamics:

Global small volume parenteral market is primarily driven by the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, cancer, and respiratory diseases. As per the estimates of World Health Organization (WHO), chronic diseases accounted for over 70% of all deaths worldwide in 2020. Growing geriatric population base which is also susceptible to multiple health issues, has intensified the demand for small volume parenteral formulations to manage complex conditions. Furthermore, advantages such as precise dosing, immediate delivery of medication, and bypassing gastrointestinal absorption have augmented the adoption of small volume parenteral. However, high costs associated with parenteral drug development and stringent regulatory framework for manufacturing injectable drugs continues to restrict the market growth. On the other hand, ongoing advancements in novel drug delivery systems are expected to unleash lucrative opportunities for stakeholders.

Key features of the study:

This report provides in-depth analysis of the global small volume parenteral market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global small volume parenteral market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Fresenius Kabi AG, Baxter, Sichuan Kelun, BML Parenteral Drugs, ICU Medical, Inc., Pfizer Inc., Becton Dickinson and Company, B. Braun Melsungen AG, WuXi AppTec , Akums Drugs & Pharmaceuticals Ltd., Orion Corporation, Rusoma Laboratories Private Limited, Higgs Healthcare and Syntegon Technology GmbH
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global small volume parenteral market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global small volume parenteral market

Detailed Segmentation:

Global Small Volume Parenteral Market, By Form
- Liquid
- Dry
Global Small Volume Parenteral Market, By Dosage Type
- Single-dose
- Multiple-dose
Global Small Volume Parenteral Market, By Packaging Type
- Ampoules
- Vials
- Pre-filled Syringes
- Cartridges
- Bottles
- Others
Global Small Volume Parenteral Market, By Indication Type
- Pain Management
- Cancer Care
- Malnourishment
- Gastrointestinal disorder/Diarrhea
- Diabetes
- Others
Global Small Volume Parenteral Market, By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
Global Small Volume Parenteral Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles
- Fresenius Kabi AG
- Baxter
- Sichuan Kelun
- BML Parenteral Drugs
- ICU Medical, Inc.
- Pfizer Inc.
- Becton Dickinson and Company
- Braun Melsungen AG
- WuXi AppTec
- Akums Drugs & Pharmaceuticals Ltd.
- Orion Corporation
- Rusoma Laboratories Private Limited
- Higgs Healthcare
- Syntegon Technology GmbH

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Top 3 Market Findings
- Top 3 Market Opportunity

3. Key Industry Insights

Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancement
Merger, Acquisition and Collaboration Scenario
Recent Product Approvals/Launches
Company Market Share Analysis

4. Small Volume Parenteral Market, By Form, 2020 - 2032 ( US$ Billion)

Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Segment Trends
Liquid, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
Dry, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)

5. Small Volume Parenteral Market, By Dose Type, 2020 - 2032 ( US$ Billion)

Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
Single-dose, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
Multiple-dose, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)

6. Small Volume Parenteral Market, By Packaging Type, 2020 - 2032 ( US$ Billion)

Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Segment Trends
Ampoules, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
Vials, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
Pre-filled Syringes, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
Cartridges, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
Bottles, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
Others, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)

7. Small Volume Parenteral Market, By Indication Type, 2020 - 2032 ( US$ Billion)

Introduction
- Market Share Analysis, 2020 - 2032, ( US$ Billion)
- Segment Trends
Pain Management
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
Cancer Care, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
Malnourishment, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
Gastrointestinal Disorder/diarrhea, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
Diabetes, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
Others, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)

8. Small Volume Parenteral Market, By End User, 2020 - 2032 ( US$ Billion)

Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Segment Trends
Hospitals, 2020 - 2032( US$ Billion)
Clinics, 2020 - 2032( US$ Billion)
Ambulatory Surgical Centers, 2020 - 2032( US$ Billion)
Others, 2020 - 2032( US$ Billion)

9. Small Volume Parenteral Market, By Region, 2020 - 2032 ( US$ Billion)

Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Segment Trends
By Region
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
North America
- Introduction
- Market Size and Forecast, By Form, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Dose Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Indication Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By End User, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Country, 2020 - 2032, ( US$ Billion)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, By Form, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Dose Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Indication Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By End User, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Country, 2020 - 2032, ( US$ Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest Of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Form, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Dose Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Indication Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By End User, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Country, 2020 - 2032, ( US$ Billion)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest Of Asia Pacific
Middle East & Africa
- Introduction
- Market Size and Forecast, By Form, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Dose Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Indication Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By End User, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Country, 2020 - 2032, ( US$ Billion)
  - GCC
  - Israel
  - Rest Of Middle East
Latin America
- Introduction
- Market Size and Forecast, By Form, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Dose Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Indication Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By End User, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Country, 2020 - 2032, ( US$ Billion)
  - Brazil
  - Mexico
  - Argentina

10. Company Profiles - Small Volume Parenteral Market

Fresenius Kabi AG
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
Strategic Overview
Baxter
Sichuan Kelun
BML Parenteral Drugs
ICU Medical, Inc.
Pfizer Inc.
Becton Dickinson and Company
B. Braun Melsungen AG
WuXi AppTec
Akums Drugs & Pharmaceuticals Ltd.
Orion Corporation
Rusoma Laboratories Private Limited
Higgs Healthcare
Syntegon Technology GmbH

11. References and Research Methodology

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

全球低剂量肠外药物市场按配方、剂型、包装类型、适应症、最终用户和地区划分